Braun et al., 2006 - Google Patents
NF-κB constitutes a potential therapeutic target in high-risk myelodysplastic syndromeBraun et al., 2006
View HTML- Document ID
- 8366806155575385584
- Author
- Braun T
- Carvalho G
- Coquelle A
- Vozenin M
- Lepelley P
- Hirsch F
- Kiladjian J
- Ribrag V
- Fenaux P
- Kroemer G
- Publication year
- Publication venue
- Blood
External Links
Snippet
Myelodysplastic syndrome (MDS) is a preneoplastic condition that frequently develops into overt acute myeloid leukemia (AML). The P39 MDS/AML cell line manifested constitutive NF- κB activation. In this cell line, NF-κB inhibition by small interfering RNAs specific for p65 or …
- 201000003793 myelodysplastic syndrome 0 title abstract description 135
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
- G01N33/57407—Specifically defined cancers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Braun et al. | NF-κB constitutes a potential therapeutic target in high-risk myelodysplastic syndrome | |
Fiorcari et al. | Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia | |
Sors et al. | Down-regulating constitutive activation of the NF-κB canonical pathway overcomes the resistance of cutaneous T-cell lymphoma to apoptosis | |
Ci et al. | The BCL6 transcriptional program features repression of multiple oncogenes in primary B cells and is deregulated in DLBCL | |
Witko-Sarsat et al. | Proliferating cell nuclear antigen acts as a cytoplasmic platform controlling human neutrophil survival | |
Maianski et al. | Granulocyte colony-stimulating factor inhibits the mitochondria-dependent activation of caspase-3 in neutrophils | |
Giri et al. | Decreased suppression of CD8+ and CD4+ T cells by peripheral regulatory T cells in generalized vitiligo due to reduced NFATC1 and FOXP3 proteins | |
Melichar et al. | Neopterin as a biomarker of immune response in cancer patients | |
Hahntow et al. | Cyclin-dependent kinase inhibitor Roscovitine induces apoptosis in chronic lymphocytic leukemia cells | |
McConnell et al. | Activation of a caspase-9-mediated apoptotic pathway by subcellular redistribution of the novel caspase recruitment domain protein TMS1 | |
Nimmanapalli et al. | Regulation of 17-AAG—induced apoptosis: role of Bcl-2, Bcl-xL, and Bax downstream of 17-AAG—mediated down-regulation of Akt, Raf-1, and Src kinases | |
Kashiwakura et al. | Down-regulation of inhibition of differentiation-1 via activation of activating transcription factor 3 and smad regulates reic/dickkopf-3–induced apoptosis | |
Zhang et al. | LncRNA SNHG14 promotes the development of cervical cancer and predicts poor prognosis. | |
Cash et al. | Loss of the Birt–Hogg–Dubé tumor suppressor results in apoptotic resistance due to aberrant TGFβ-mediated transcription | |
Chou et al. | The thrombopoietin/MPL/Bcl-xL pathway is essential for survival and self-renewal in human preleukemia induced by AML1-ETO | |
Vanderwerf et al. | TLR8-dependent TNF-α overexpression in Fanconi anemia group C cells | |
Zhou et al. | One siRNA pool targeting the λ constant region stops λ light-chain production and causes terminal endoplasmic reticulum stress | |
Lång et al. | The arsenic-based cure of acute promyelocytic leukemia promotes cytoplasmic sequestration of PML and PML/RARA through inhibition of PML body recycling | |
Zhang et al. | TGF-β1 induces epithelial-to-mesenchymal transition via inhibiting mitochondrial functions in A549 cells | |
Sun et al. | Abnormal Cullin1 neddylation-mediated p21 accumulation participates in the pathogenesis of recurrent spontaneous abortion by regulating trophoblast cell proliferation and differentiation | |
Gu et al. | Inhibition of MDM2 by a rhein-derived compound AQ-101 suppresses cancer development in SCID mice | |
Nakamura et al. | Improvement of gemcitabine sensitivity of p53-mutated pancreatic cancer MiaPaCa-2 cells by RUNX2 depletion-mediated augmentation of TAp73-dependent cell death | |
He et al. | Upregulation of nuclear transporter, Kpnβ1, contributes to accelerated cell proliferation-and cell adhesion-mediated drug resistance (CAM-DR) in diffuse large B-cell lymphoma | |
Zhao et al. | LncRNA LINC01088 inhibits the function of trophoblast cells, activates the MAPK-signaling pathway and associates with recurrent pregnancy loss | |
Wada et al. | Flow cytometric identification and cell-line establishment of macrophages in naked mole-rats |